Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Dean Y. Li
Person

Dean Y. Li

Tracked across 2 events · 195 articles · First seen Jul 16, 2026 · Last active Aug 20, 2026

Sentiment
30
Attention
8
Events
2
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
8 60
Tech
Moderna Merck mRNA melanoma vaccine trial success
Moderna and Merck & Co. announced on August 19, 2026, that their personalized mRNA cancer vaccine, Intismeran, combined with Merck's immunotherapy drug Pembrolizumab, met its primary and secondary goals in a Phase 3 trial for…
Impact: As President of Merck Research Laboratories, Li commented on the potential of adjuvant therapy, supporting the scientific rationale.
Aug 19, 2026 · 102 articles
6 0
Regulatory
FDA approves Merck's Lipfendra cholesterol pill
Impact: President of Merck Research Laboratories; commented on the drug's potential.
Jul 16, 2026 · 93 articles
Relationships (4)
Stéphane Bancel ↔ Dean Y. Li
Stéphane Bancel ↔ Dean Y. Li
Moderna ↔ Dean Y. Li
Moderna ↔ Dean Y. Li
ERGEN INTELLIGENCE
Track Dean Y. Li live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.